Prospects and problems in synthetic vaccine development: what did we learn from the cholera toxin system?
Jacob
C O
CO
Department of Microbiology and Immunology, Stanford University School of Medicine, California 94305.
D000276:Adjuvants, Immunologic; D000595:Amino Acid Sequence; D000818:Animals; D002772:Cholera Toxin / Q000235:genetics / Q000276:immunology*; D022121:Cholera Vaccines / Q000008:administration & dosage / Q000276:immunology*; D004274:DNA, Recombinant; D004337:Drug Carriers; D000939:Epitopes / Q000276:immunology; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology; D014612:Vaccines / Q000008:administration & dosage; D014614:Vaccines, Synthetic / Q000008:administration & dosage
D000276:Adjuvants, Immunologic; D022121:Cholera Vaccines; D004274:DNA, Recombinant; D004337:Drug Carriers; D000939:Epitopes; D010455:Peptides; D014612:Vaccines; D014614:Vaccines, Synthetic; D002772:Cholera Toxin